CardioScript International

CardioScript International is a specialized medical communications and consultancy agency that focuses exclusively on the cardiovascular and metabolic therapeutic areas. Founded in 1996 and based in the Netherlands, the company provides high-level scientific writing, publication planning, and strategic advisory services to global pharmaceutical and biotechnology firms. The agency is particularly renowned for its expertise in lipidology and atherosclerosis, often serving as a key partner for major clinical trial publications and product launches. In 2015, CardioScript International was acquired by Aptus Health (then a subsidiary of Merck & Co.), and it subsequently became part of the WebMD Health Corp. network following WebMD's acquisition of Aptus Health in 2019.